JPIAMR Workshop “The interplay between AMR Surveillance and Science”

Oslo, Norway October 12-13. 2016

Surveillance is a key component of any strategy to counteract the spread and consequences of antimicrobial resistance (AMR).  Present surveillance systems have severe limitations  and the purpose of the workshop is to explore how surveillance systems can be developed to support scientific research, and how science can fill knowledge gaps to optimize surveillance. 

The workshop will be hosted by the Norwegian Research Council as a lunch-to-lunch meeting for invited participants on October 12-13 in Oslo, Norway. The discussion will revolve around selected keynote lectures, breakout sessions and plenary discussions.

Program

October 12 2016       

Lunch

  • Welcome and scope of the workshop
  • Gunnar Skov Simonsen (University of Tromsø, Norway)
  • “The use of AMR surveillance data in scientific research – Opportunities and limitations”

Liselotte Diaz Högberg (European Centre for Disease Prevention and Control, Sweden)

  • “The global transition from phenotypic to genotypic AMR surveillance – How do we get there? “

Neil Woodford (Public Health England, UK)

  • Breakout session in two groups to identify knowledge gaps in AMR surveillance and suggest funding calls for scientific research to amend these
    • AMR surveillance for patient management

Hajo Grundmann (Universitätsklinikum Freiburg, Germany)

    • AMR surveillance in non-human reservoirs
    • Bruno Gonzalez-Zorn (Complutense University, Spain)

October 13 2016

Breakfast

  • “Novel technologies and strategies for surveillance”
  • David Aanensen (Imperial College, UK)
  • Reports from breakout sessions
    • “The interplay between surveillance and science to optimize patient management”

Hajo Grundmann (Universitätsklinikum Freiburg, Germany)

    • “The interplay between surveillance and science to contain non-human AMR reservoirs”

Bruno Gonzalez-Zorn (Complutense University, Spain)

  • Plenary discussion on future JPI-AMR funding call for AMR surveillance.
  • Martin Steinbakk (Norwegian Institute of Public Health, Norway)